Drug Designation Software In Europe
-
based in UNITED KINGDOM
A single platform for ligand-based and structure-based drug design that enables research chemists to discover novel small molecules more efficiently and ...
-
by Iktosbased in FRANCE
Makya is the first user-friendly SaaS platform for AI-driven de novo drug design focused on Multi-Parametric Optimization ...
-
based in USA
the Food and Drug Administration's (FDA) design control guidelines. MasterControl offers design control software systems for the design history files (DHF) which are established for each device to house this documentation for the ...
-
based in GERMANY
Reliable predictions to anticipate risks. Interlinked data to find new targets and design novel drugs. Real-world evidence to evaluate success. These capabilities eliminate the uncertainties that limit drug development but are data-intensive and experimentally inaccessible. Molecular Health Dataome Technology offers powerful solutions to ...
-
based in USA
We are developing novel causal artificial intelligence and machine learning (AI/ML) and unconventional computing strategies to better understand human biology – and then apply these to deliver better medicine and improve health for people around the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you